ARDUINO
Today Arduino, the open-source leader famous for making technology accessible to all, launches the Plug and Make Kit to help people of all ages take the first step into electronics in a fun and easy way. Anyone can make their own smart, connected device and get to know the Internet of Things (IoT) firsthand.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240711636287/en/
The new Plug and Make Kit is Arduino's new gateway to fun, quick, easy technology. An innovative hardware technology removes all frictions so even beginners can create their first connected device in a single session: choosing from a game controller, a weather station, a smart timer and much more – the possibilities are endless! (Photo: Business Wire)
Since 2005, Arduino has built a global community of 33+ million users thanks to products like the iconic Arduino UNO® microcontroller, Arduino Starter Kit, Arduino Cloud, the hugely popular Arduino IDE software, and a slew of educational kits for learners at all levels. Each addition to the ecosystem is meant to help people connect to their passions, innovate, and play an active role in technology.
Now, the new Arduino Plug and Make Kit ups the ante and lowers barriers more than ever, allowing anyone to develop functional smart devices in a single session. Even beginners and young inventors can start creating new projects quickly and easily, and feel the huge sense of accomplishment that comes with building something with their own hands, learning and having fun.
“The Plug and Make Kit is Arduino’s new entry point into the world of IoT and electronics: one that is more accessible, fun and engaging than ever. No matter their age, background or interests, everyone can experience that first taste of technology,” comments Fabio Violante, CEO of Arduino.
Go from idea to fully functional smart device in a single session
The new Plug and Make Kit experience starts with 7 fun and useful projects that allow anyone to assemble components in a snap, without soldering or breadboards, and to control the new device via intuitive Arduino Cloud dashboards, even from their smartphone.
- Weather Report: Never forget your umbrella, with a visual forecast for rain!
- Hourglass: Who needs an egg timer? Customize your own digital hourglass
- Eco Watch: Make sure your plants thrive in the perfect temperature and humidity
- Game Controller: Level up with your very own HID (Human Interface Device) gamepad
- Sonic Synth: Get one step closer to being a rockstar, DJ or sound engineer!
- Smart Lights: Turn the lights on and off from your couch, via your smartphone
- Touchless Lamp: Control lights with a simple gesture
After the launch, more projects will be released online to give users more and more ideas.
It’s just the beginning!
“The components in the Plug and Make Kit can be used to create endless applications – also swiftly integrating with Arduino’s full ecosystem of hardware and software tools. In fact, we can expect Arduino’s vast community to develop and share many original ideas soon,” concludes Fabio Violante, CEO at Arduino.
The Plug and Make Kit offers the easiest, most fun introduction to a world of opportunities and wonder, where technology is open to all. It’s for everyone, because it’s the simplest kit Arduino has ever made.
Intuitive hardware meets easy Cloud integration
The Plug and Make Kit combines Arduino’s extensive resources and complete ecosystem with an innovative hardware approach. It includes:
- Arduino UNO R4 WiFi main board: this maker’s favorite is a unique combination of simplicity for first-time users and potential for future implementations. The board is based on Renesas RA4M1 Arm® Cortex® M4 as main microcontroller and Espressif ESP32 S3 as connectivity device.
- Modulino® sensors and actuators: buzzer, 6-axis IMU, temperature and humidity sensor, buttons, knob, LED strip and time-of-flight proximity sensor – that’s 7 nodes for different functionalities! They simply snap together, with no risk of mistakes. Several Modulino feature the new STM 32C0 microcontroller based on Arm® Cortex® M0 architecture.
- The Modulino Base: a whole new physical frame designed to keep projects looking and feeling neat.
- Online resources to swiftly integrate with the Arduino ecosystem: a dedicated content platform in multiple languages, free and easy-to-use programming tools, a smartphone app to monitor and control IoT devices, and readily available Arduino Cloud templates to get up and running in minutes.
The technology behind the kit
The kit was developed by choosing the best components for durability and convenience, teaming up with leaders like Renesas, Espressif and STMicroelectronics.
“Last year we teamed-up with Arduino for the development of the new Arduino UNO R4, the quintessential board for rapid prototyping – upgrading the device to a 32-bit Arm® architecture, opening up a new range of possibilities. Now we are extremely happy to see our RA4M1 Microcontroller and Buck Regulator ISL854102FRZ technology being deployed within Arduino’s Plug and Make Kit to foster the new generation of innovators, lowering the barriers to entry into technology,” said Mohammed Dogar, VP and Head of Global Business Development and Ecosystem at Renesas Electronics.
“We’re proud to support Arduino on its mission to allow anyone to innovate, whether in harsh industrial environments or in the comfort of their homes. The intuitive Modulino® nodes incorporate the high technological standard of our STM32C0 microcontrollers and our sensors, both MEMS (LSM6DSOX, LPS22HB) and Time-of-Flight (VL53L4CD): this is the kind of solution that truly puts great potential into people’s hands, giving them the best tools along with the freedom to explore,” adds Alessandro Maloberti, Partner Ecosystem Director, STMicroelectronics.
Where to find the Plug and Make Kit
The Plug and Make Kit can be purchased worldwide from the Arduino Store, as well as from major distributors including Digikey, Farnell, Mouser Electronics, Reichelt, the RS Group and many other official partners.
About Arduino
Arduino is the leading open-source hardware and software company in the world. Born to provide an easy-to-use platform for anyone making interactive projects, Arduino has reached a growing community and adapted to new needs and challenges, branching out into products for IoT, wearables, 3D printing, and embedded environments. As of today, the Arduino community includes over 33 million active users.
(images available for download at this link)
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240711636287/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The Rock-It Company Expands Fine Art Logistics Capabilities of DIETL Through Acquisition of Several Strategic Infrastructure Services5.1.2026 15:00:00 CET | Press release
The acquisition strengthens DIETL’s fine art logistics operations through expanded access to specialized storage, handling and customs services. The Rock-It Company announced today that DIETL has acquired multiple fine art logistics specialists, strengthening its infrastructure and expanding access to specialized services across key U.S. art markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260105175923/en/ The Rock-It Company Expands Fine Art Logistics Capabilities of DIETL Through Acquisition of Several Strategic Infrastructure Services The acquired companies include Delaware Freeport, Delaware National Art Company, Techno Export, and Registrar Technologies. Together, these businesses add depth across fine art storage, handling, packing, crating, installation support, customs brokerage, and technology-enabled logistics services, complementing DIETL’s existing operations. Delaware Freeport, a provider of high-security
TII Launches Falcon Reasoning: Best 7B AI Model Globally, Also Outperforms Larger Models5.1.2026 14:54:00 CET | Press release
Falcon H1R 7B Packs Advanced Reasoning into a Compact 7 Billion Parameter Model Optimized for Speed and Efficiency TII’s Latest AI Model Outperforms Larger Rivals from Microsoft, Alibaba, and NVIDIA on Key Benchmarks The Technology Innovation Institute (TII), the applied research pillar of Abu Dhabi’s Advanced Technology Research Council (ATRC), has announced the release of Falcon H1R 7B, a next-generation AI model that takes a significant step toward making advanced AI more accessible than ever, by delivering world-class reasoning performance in a compact, efficient, and openly available format. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260105981339/en/ TII Launches Falcon Reasoning: Best 7B AI Model Globally, Also Outperforms Larger Models (Graphic: AETOSWire) With just 7 billion parameters, Falcon H1R 7B challenges and, in many cases, outperforms larger open-source AI models from around the world, including models fr
Curing the Incurable with ‘Biological Age Zero’ Cells: Clonell™ Launches the Ultimate Regenerative Medicine Platform5.1.2026 14:00:00 CET | Press release
Fundamental Cure for Intractable and Incurable Diseases using ‘Biological Age Zero’ Cells Derived from Patient’s Own Cells via SCNT TechnologyWorld's First Therapy Platform Simultaneously Solving Immune Rejection and Inheritance of Cellular Aging—The Major Hurdles of Existing Stem Cell TherapiesDrastically Improving Treatment Accessibility through the New Paradigm, ‘Patient-Initiated Clinical Trial™’, which Overcomes Existing Clinical Limitations Clonell Therapeutics, Inc., a leading biotechnology company dedicated to curing intractable and incurable diseases, announced today the official launch of the world's first 'Patient-Specific Embryonic Stem Cell (Somatic Cell Nuclear Transfer-derived Embryonic Stem Cell, hereinafter SCNT-ESC)' therapy platform based on Somatic Cell Nuclear Transfer (SCNT) technology. Concurrently, the company has initiated its innovative 'Patient-Initiated Clinical Trial™' to apply this breakthrough technology directly to patients. This platform launch is evalu
HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq5.1.2026 13:30:00 CET | Press release
Helus Pharma builds on the strong foundation originally created as Cybin Inc., reflecting the Company’s ongoing transformation to a commercial stage pharmaceutical company Helus Pharma commences trading on Nasdaq Global Market (“Nasdaq”) and on Cboe Canada under ticker symbol: HELP Helus Pharma continues to progress its portfolio of novel serotonergic agonists (“NSAs”), with the goal of developing treatments designed to redefine mental health care, including HLP004 for the treatment of generalized anxiety disorder, with Phase 2 topline data readout expected in Q1 2026 Preparations in progress for the commercialization of HLP003, Helus Pharma’s NSA in Phase 3 clinical development, which has been granted Breakthrough Therapy Designation by the FDA for the adjunctive treatment of major depressive disorder This news release constitutes a “designated news release” for the purpose of the Company’s prospectus supplement dated December 30, 2025, to it short form base shelf prospectus dated Sep
Incyte Announces Positive Topline Results from Pivotal Study of Tafasitamab (Monjuvi®/Minjuvi®) as a First-line Treatment for Diffuse Large B-Cell Lymphoma5.1.2026 13:30:00 CET | Press release
- Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP met its primary endpoint of progression-free survival (PFS) - Based on these results, Incyte plans to file a supplemental Biologics License Application (sBLA) for tafasitamab and lenalidomide in addition to R-CHOP in first-line diffuse large B-cell lymphoma (DLBCL) in the first half of 2026 Incyte (Nasdaq:INCY) today announced positive topline results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19 targeting monoclonal antibody, and lenalidomide in addition to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone) compared to R-CHOP alone as a first-line treatment for adults with newly diagnosed diffuse large B-cell lymphoma (DLBCL) with an International Prognostic Index (IPI) score of three to five (3-5) for patients >60 years o
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom